Cresset Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Cresset Asset Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,238	Closed	-$11K	–	1172
2021 Q4	$11K	Buy	+10,238	New	+$15.8K	﹤0.01%	1118
2019 Q2	–	Sell	-63	Closed	-$2K	–	1802
2019 Q1	$2K	Buy	+63	New	+$2.11K	﹤0.01%	1715

Other funds holding ASXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cresset Asset Management's ASXC Position: Q1 2022 in Review

Cresset Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q1 2022, closing a stake of 10,238 shares — an estimated $11K sold.

Cresset Asset Management first reported a position in ASXC in Q1 2019 and held it in 2 quarters. The position peaked at $11K in Q4 2021. 115 funds tracked by Wall St. Rank hold ASXC as of Q1 2022.

Cresset Asset Management reported no remaining Asensus Surgical, Inc. position as of Q1 2022 after selling out during the quarter.
Cresset Asset Management sold 10,238 Asensus Surgical, Inc. shares in Q1 2022, an estimated $11K.
Cresset Asset Management first reported a position in Asensus Surgical, Inc. in Q1 2019 and held it in 2 quarters.
Cresset Asset Management's Asensus Surgical, Inc. position peaked at $11K in Q4 2021.
115 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2022.

Based on Cresset Asset Management's 13F filing for Q1 2022, filed 16 May 2022.